No abstract available
MeSH terms
-
Anti-HIV Agents / pharmacokinetics*
-
Anti-HIV Agents / therapeutic use
-
Cobicistat / pharmacokinetics*
-
Cobicistat / therapeutic use
-
Cytochrome P-450 CYP3A Inhibitors / pharmacokinetics*
-
Cytochrome P-450 CYP3A Inhibitors / therapeutic use
-
Darunavir / pharmacokinetics*
-
Darunavir / therapeutic use
-
Drug Therapy, Combination
-
Female
-
HIV Infections / drug therapy*
-
HIV Integrase Inhibitors / pharmacokinetics*
-
HIV Integrase Inhibitors / therapeutic use
-
HIV Protease Inhibitors / pharmacokinetics*
-
HIV Protease Inhibitors / therapeutic use
-
HIV-1 / drug effects
-
Heterocyclic Compounds, 3-Ring / pharmacokinetics*
-
Heterocyclic Compounds, 3-Ring / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Oxazines
-
Piperazines
-
Pyridones
-
Ritonavir / pharmacokinetics*
-
Ritonavir / therapeutic use
Substances
-
Anti-HIV Agents
-
Cytochrome P-450 CYP3A Inhibitors
-
HIV Integrase Inhibitors
-
HIV Protease Inhibitors
-
Heterocyclic Compounds, 3-Ring
-
Oxazines
-
Piperazines
-
Pyridones
-
dolutegravir
-
Cobicistat
-
Ritonavir
-
Darunavir